High frequency oscillatory ventilation in a cohort of children with respiratory failure.
Claire A StewartNadir YehyaLin FeiRanjit S ChimaPublished in: Pediatric pulmonology (2018)
In this cohort of patients, use of HFOV for pediatric respiratory failure demonstrated a mortality rate in keeping with published data. The presence of an immunocompromised condition was a risk factor for mortality in severe respiratory failure with SCT recipients having the lowest survival rate. The OI at 24 h was the best predictor of mortality, especially in immunocompromised and SCT patients.
Keyphrases
- respiratory failure
- extracorporeal membrane oxygenation
- high frequency
- mechanical ventilation
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- ejection fraction
- prognostic factors
- cardiovascular events
- risk factors
- transcranial magnetic stimulation
- randomized controlled trial
- type diabetes
- young adults
- cardiovascular disease
- intensive care unit
- patient reported outcomes
- coronary artery disease
- artificial intelligence